NUVO PHARM
GenericsNUVO PHARM is a generic drug manufacturer focused on Neurology.
NUVO PHARM's Key Drugs
NUVO PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
NUVO PHARM's Recent FDA Approvals
New NDA/BLA approvals for NUVO PHARM over the last two years — novel drugs only, excluding generics and label supplements.
NUVO PHARM's Therapeutic Areas
NUVO PHARM's approved drugs and pipeline span 1 therapeutic area, led by Neurology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
NUVO PHARM's Top Competitors
NUVO PHARM's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
NUVO PHARM Pipeline Snapshot
Active clinical trials for NUVO PHARM across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1986-02-25
- Latest
- 2026-06-18
- Applications
- 8